Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All nitric oxide studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchNitric OxideNitric Oxide (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19

Hedenstierna et al., Nitric Oxide, doi:10.1016/j.niox.2020.06.005
Jun 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Hypothesis that reduced incidence of COVID-19 cases for smokers in some studies is due to bursts of high concentrations of nitric oxide during smoking.
Reviews covering nitric oxide for COVID-19 include1-5.
Hedenstierna et al., 23 Jun 2020, peer-reviewed, 5 authors. Contact: goran.hedenstierna@medsci.uu.se.
This PaperNitric OxideAll
Abstract: Nitric Oxide 103 (2020) 1–3 Contents lists available at ScienceDirect Nitric Oxide journal homepage: www.elsevier.com/locate/yniox Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19 €ran Hedenstierna a, *, Luni Chen b, Magnus Hedenstierna c, Robert Lieberman d, David H. Fine e Go a Department of Medical Sciences, Uppsala University, Uppsala, Sweden Department of MTC, Karolinska Institute, Solna, Sweden c Department of Infectious Diseases, Danderyd Hospital, Danderyd, Sweden d Contello Consulting LLC, New Jersey, USA e Pieto LLC, Florida, USA b A R T I C L E I N F O A B S T R A C T Keywords: Nitric oxide Smoking Viral suppression Covid-19 It has long been suggested that NO may inhibit an early stage in viral replication. Furthermore, in vitro tests have shown that NO inhibits the replication cycle of severe acute respiratory syndrome coronavirus. Despite smoking being listed as a risk factor to contract Covid-19, only a low proportion of the smokers suffered from SARS-corona infection in China 2003, and from Covid-19 in China, Europe and the US. We hypothesize, that the intermittent bursts of high NO concentration in cigarette smoke may be a mechanism in protecting against the virus. Mainstream smoke from cigarettes contains NO at peak concentrations of between about 250 ppm and 1350 ppm in each puff as compared to medicinal use of no more than 80 to a maximum of 160 ppm. The diffusion of NO through the cell wall to reach the virus should be significantly more effective at the very high NO concentration in the smoke, according to classic laws of physics. The only oxide of nitrogen in the mainstream smoke is NO, and the NO2 concentration that is inhaled is very low or undetectable, and methemoglobin levels are lower in smokers than non-smokers, reasonably explained by the breaths of air in between the puffs that wash out the NO. Specialized iNO machines can now be developed to provide the drug intermittently in short bursts at high concentration dose, which would then provide both a preventative drug for those at high risk, as well as an effective treatment, without the health hazards associated with smoking. In this commentary we present a hypothesis that inhaled nitric oxide, iNO, delivered in short bursts at a high concentration, has a protective effect against Covid-19. It has long been suggested that NO may inhibit an early stage in viral replication and thus prevent viral spread, promoting viral clearance and recovery of the host [1]. In a recent letter, Ignarro assumed this to apply also to inhalation of NO (iNO) [2], supported by findings in a previous SARS-corona epidemic. One of the authors of this commentary treated SARS patients in Beijing with iNO in a limited number of patients [3]. iNO dramatically improved arterial oxygenation, expressed as arterial oxygen tension, PaO2, divided by the inspired oxygen fraction, FIO2, within 2–3 days. The PaO2/FIO2 ratio increased from a mean of 97–260 mmHg and, as shown in Fig. 1, the transcutaneous O2 saturation increased and respiratory support was at the same time reduced or discontinued. The 270% increase in the PaO2/FIO2 ratio is many times larger than commonly seen when treating ARDS patients with iNO, where an improvement by 20% is considered significant [4]. A similar low PaO2/FIO2 ratio (110 mmHg) was also reported in another study with a larger number of patients [5]. This suggests that the SARS pa­ tients benefitted more by iNO with..
{ 'indexed': {'date-parts': [[2023, 3, 7]], 'date-time': '2023-03-07T14:26:32Z', 'timestamp': 1678199192431}, 'reference-count': 26, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2020, 10, 1]], 'date-time': '2020-10-01T00:00:00Z', 'timestamp': 1601510400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2020, 6, 23]], 'date-time': '2020-06-23T00:00:00Z', 'timestamp': 1592870400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 10]]}, 'DOI': '10.1016/j.niox.2020.06.005', 'type': 'journal-article', 'created': {'date-parts': [[2020, 6, 24]], 'date-time': '2020-06-24T01:11:40Z', 'timestamp': 1592961100000}, 'page': '1-3', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 37, 'title': 'Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19', 'prefix': '10.1016', 'volume': '103', 'author': [ {'given': 'Göran', 'family': 'Hedenstierna', 'sequence': 'first', 'affiliation': []}, {'given': 'Luni', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-8539-9820', 'authenticated-orcid': False, 'given': 'Magnus', 'family': 'Hedenstierna', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert', 'family': 'Lieberman', 'sequence': 'additional', 'affiliation': []}, {'given': 'David H.', 'family': 'Fine', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '6', 'key': '10.1016/j.niox.2020.06.005_bib1', 'doi-asserted-by': 'crossref', 'first-page': '4547', 'DOI': '10.1128/JVI.72.6.4547-4551.1998', 'article-title': 'Does nitric oxide play a critical role in viral infections?', 'volume': '72', 'author': 'Reiss', 'year': '1998', 'journal-title': 'J. Virol.'}, { 'key': '10.1016/j.niox.2020.06.005_bib2', 'author': 'Ignarro', 'year': '2020', 'journal-title': 'Br. J. Pharmacol.'}, { 'issue': '10', 'key': '10.1016/j.niox.2020.06.005_bib3', 'doi-asserted-by': 'crossref', 'first-page': '1531', 'DOI': '10.1086/425357', 'article-title': 'Inhalation of nitric oxide in the treatment of severe acute respiratory ' 'syndrome: a rescue trial in Beijing', 'volume': '39', 'author': 'Chen', 'year': '2004', 'journal-title': 'Clin. Infect. Dis.'}, { 'issue': '9', 'key': '10.1016/j.niox.2020.06.005_bib4', 'doi-asserted-by': 'crossref', 'first-page': '911', 'DOI': '10.1007/s001340050982', 'article-title': 'Inhalation of nitric oxide in acute lung injury: results of a European ' 'multicentre study. The European Study Group of Inhaled Nitric Oxide', 'volume': '25', 'author': 'Lundin', 'year': '1999', 'journal-title': 'Intensive Care Med.'}, { 'issue': '9371', 'key': '10.1016/j.niox.2020.06.005_bib5', 'doi-asserted-by': 'crossref', 'first-page': '1767', 'DOI': '10.1016/S0140-6736(03)13412-5', 'article-title': 'HKU/UCH SARS Study Group : clinical progression and viral load in a ' 'community outbreak of coronavirus-associated SARS pneumonia: a ' 'prospective study', 'volume': '361', 'author': 'Peiris', 'year': '2003', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': '10.1016/j.niox.2020.06.005_bib6', 'doi-asserted-by': 'crossref', 'first-page': '1966', 'DOI': '10.1128/JVI.79.3.1966-1969.2005', 'article-title': 'Nitric oxide inhibits the replication cycle of severe acute respiratory ' 'syndrome coronavirus', 'volume': '79', 'author': 'Akerstrom', 'year': '2005', 'journal-title': 'J. Virol.'}, { 'issue': '4', 'key': '10.1016/j.niox.2020.06.005_bib7', 'doi-asserted-by': 'crossref', 'first-page': '223', 'DOI': '10.1016/j.ijid.2004.04.012', 'article-title': 'Inhibition of SARS-coronavirus infection in vitro by ' 'S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound', 'volume': '8', 'author': 'Keyaerts', 'year': '2004', 'journal-title': 'Int. J. Infect. Dis.'}, { 'issue': '5', 'key': '10.1016/j.niox.2020.06.005_bib8', 'doi-asserted-by': 'crossref', 'first-page': '475', 'DOI': '10.1016/S2213-2600(20)30079-5', 'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 ' 'pneumonia in Wuhan, China: a single-centered, retrospective, ' 'observational study', 'volume': '8', 'author': 'Yang', 'year': '2020', 'journal-title': 'Lancet Respir. Med.'}, { 'issue': '9', 'key': '10.1016/j.niox.2020.06.005_bib9', 'doi-asserted-by': 'crossref', 'first-page': '1064', 'DOI': '10.3201/eid0909.030362', 'article-title': 'Severe acute respiratory syndrome: clinical outcome and prognostic ' 'correlates', 'volume': '9', 'author': 'Tsui', 'year': '2003', 'journal-title': 'Emerg. Infect. Dis.'}, { 'key': '10.1016/j.niox.2020.06.005_bib10', 'doi-asserted-by': 'crossref', 'article-title': 'COVID-19 and smoking', 'author': 'Berlin', 'year': '2020', 'journal-title': 'Nicotine Tob. Res.', 'DOI': '10.1093/ntr/ntaa059'}, { 'issue': 'Suppl 1', 'key': '10.1016/j.niox.2020.06.005_bib11', 'doi-asserted-by': 'crossref', 'first-page': 'S21', 'DOI': '10.21037/tlcr.2019.03.12', 'article-title': 'Tobacco and the lung cancer epidemic in China', 'volume': '8', 'author': 'Parascandola', 'year': '2019', 'journal-title': 'Transl. Lung Cancer Res.'}, {'key': '10.1016/j.niox.2020.06.005_bib12', 'author': 'Miyara'}, { 'issue': '24', 'key': '10.1016/j.niox.2020.06.005_bib13', 'doi-asserted-by': 'crossref', 'first-page': '2372', 'DOI': '10.1056/NEJMc2010419', 'article-title': 'Clinical characteristics of covid-19 in New York city', 'volume': '382', 'author': 'Goyal', 'year': '2020', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.niox.2020.06.005_bib14', 'article-title': 'Smoking prevalence in low in symptomatic patients admitted for COVID-19', 'author': 'Gaibazzi', 'year': '2020', 'journal-title': 'MedRxiv'}, { 'key': '10.1016/j.niox.2020.06.005_bib15', 'doi-asserted-by': 'crossref', 'article-title': 'Smoking is associated with COVID-19 progression: a meta-analysis', 'author': 'Patanavanich', 'year': '2020', 'journal-title': 'Nicotine Tob. Res.', 'DOI': '10.1093/ntr/ntaa082'}, { 'key': '10.1016/j.niox.2020.06.005_bib16', 'doi-asserted-by': 'crossref', 'article-title': 'Tobacco smoking and COVID-19 infection', 'author': 'van Zyl-Smit', 'year': '2020', 'journal-title': 'Lancet Respir. Med.', 'DOI': '10.1016/S2213-2600(20)30239-3'}, { 'key': '10.1016/j.niox.2020.06.005_bib17', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.18332/tid/119324', 'article-title': 'COVID-19 and smoking: a systematic review of the evidence', 'volume': '18', 'author': 'Vardavas', 'year': '2020', 'journal-title': 'Tob. Induc. Dis.'}, { 'key': '10.1016/j.niox.2020.06.005_bib18', 'series-title': 'Nitric Oxide Yields of Cigarettes. Results for Cigarettes Sampled in ' '1996. Commissioned by Smoking Policy Unit, 135 Waterloo Road, London SE ' '1 BUG June', 'author': 'Uk Department of Health', 'year': '1998'}, { 'issue': '4', 'key': '10.1016/j.niox.2020.06.005_bib19', 'doi-asserted-by': 'crossref', 'first-page': '511', 'DOI': '10.1021/tx050220w', 'article-title': 'Quantitative puff-by-puff-resolved characterization of selected toxic ' 'compounds in cigarette mainstream smoke', 'volume': '19', 'author': 'Adam', 'year': '2006', 'journal-title': 'Chem. Res. Toxicol.'}, { 'key': '10.1016/j.niox.2020.06.005_bib20', 'first-page': '55', 'article-title': 'The effect of some nitrogenous Blen on components NO/NOx and HCN levels ' 'in Mainstream and sidestream smoke', 'volume': '12', 'author': 'Norman', 'year': '1983', 'journal-title': 'Beitrage zur Tabakforschung Int.'}, { 'issue': '9', 'key': '10.1016/j.niox.2020.06.005_bib21', 'doi-asserted-by': 'crossref', 'first-page': '817', 'DOI': '10.1136/thx.2005.056093', 'article-title': 'Exhaled nitric oxide measurements: clinical application and ' 'interpretation', 'volume': '61', 'author': 'Taylor', 'year': '2006', 'journal-title': 'Thorax'}, { 'issue': '2', 'key': '10.1016/j.niox.2020.06.005_bib22', 'doi-asserted-by': 'crossref', 'first-page': '339', 'DOI': '10.1183/09031936.06.00113705', 'article-title': 'Effect of smoking on exhaled nitric oxide and flow-independent nitric ' 'oxide exchange parameters', 'volume': '28', 'author': 'Malinovschi', 'year': '2006', 'journal-title': 'Eur. Respir. J.'}, { 'issue': '6', 'key': '10.1016/j.niox.2020.06.005_bib23', 'doi-asserted-by': 'crossref', 'first-page': '330', 'DOI': '10.1080/00039896.1985.10545943', 'article-title': 'Methemoglobin levels in smokers and non-smokers', 'volume': '40', 'author': 'Borland', 'year': '1985', 'journal-title': 'Arch. Environ. Health'}, { 'key': '10.1016/j.niox.2020.06.005_bib24', 'doi-asserted-by': 'crossref', 'first-page': '42', 'DOI': '10.1016/j.niox.2016.06.001', 'article-title': 'Nitrogen dioxide reducing ascorbic acid technologies in the ventilator ' 'circuit leads to uniform NO concentration during inspiration', 'volume': '58', 'author': 'Pezone', 'year': '2016', 'journal-title': 'Nitric Oxide'}, { 'issue': '5', 'key': '10.1016/j.niox.2020.06.005_bib25', 'doi-asserted-by': 'crossref', 'first-page': 'R895', 'DOI': '10.1152/ajpregu.00099.2018', 'article-title': 'Nicotine and the renin-angiotensin system', 'volume': '315', 'author': 'Oakes', 'year': '2018', 'journal-title': 'Am. J. Physiol. Regul. Integr. Comp. Physiol.'}, { 'issue': '5', 'key': '10.1016/j.niox.2020.06.005_bib26', 'doi-asserted-by': 'crossref', 'DOI': '10.1183/13993003.00688-2020', 'article-title': 'ACE-2 expression in the small airway epithelia of smokers and COPD ' 'patients: implications for COVID-19', 'volume': '55', 'author': 'Leung', 'year': '2020', 'journal-title': 'Eur. Respir. J.'}], 'container-title': 'Nitric Oxide', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1089860320301610?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1089860320301610?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2020, 8, 17]], 'date-time': '2020-08-17T11:30:32Z', 'timestamp': 1597663832000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1089860320301610'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 10]]}, 'references-count': 26, 'alternative-id': ['S1089860320301610'], 'URL': 'http://dx.doi.org/10.1016/j.niox.2020.06.005', 'relation': {}, 'ISSN': ['1089-8603'], 'subject': ['Cancer Research', 'Clinical Biochemistry', 'Physiology', 'Biochemistry'], 'container-title-short': 'Nitric Oxide', 'published': {'date-parts': [[2020, 10]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Nitric oxide dosed in short bursts at high concentrations may protect against ' 'Covid 19', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Nitric Oxide', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.niox.2020.06.005', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 The Author(s). Published by Elsevier Inc.', 'name': 'copyright', 'label': 'Copyright'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit